RICEBRAN TECHNOLOGIES (RIBT) Fundamental Analysis & Valuation

NASDAQ:RIBTUS7628313030

Current stock price

0.35 USD
-0.01 (-1.69%)
At close:
0.3675 USD
+0.02 (+5%)
After Hours:

This RIBT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. RIBT Profitability Analysis

1.1 Basic Checks

  • RIBT had negative earnings in the past year.
  • In the past year RIBT has reported a negative cash flow from operations.
RIBT Yearly Net Income VS EBIT VS OCF VS FCFRIBT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 -5M -10M -15M

1.2 Ratios

  • RIBT has a Return On Assets of -141.05%. This is amonst the worse of the industry: RIBT underperforms 95.70% of its industry peers.
  • Looking at the Return On Equity, with a value of -1786.67%, RIBT is doing worse than 94.62% of the companies in the same industry.
Industry RankSector Rank
ROA -141.05%
ROE -1786.67%
ROIC N/A
ROA(3y)-30.33%
ROA(5y)-30.36%
ROE(3y)-53.15%
ROE(5y)-47.52%
ROIC(3y)N/A
ROIC(5y)N/A
RIBT Yearly ROA, ROE, ROICRIBT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 0 2K 4K 6K 8K

1.3 Margins

  • RIBT does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RIBT Yearly Profit, Operating, Gross MarginsRIBT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 0 20 -20 -40 -60

0

2. RIBT Health Analysis

2.1 Basic Checks

  • RIBT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, RIBT has more shares outstanding
  • Compared to 1 year ago, RIBT has a worse debt to assets ratio.
RIBT Yearly Shares OutstandingRIBT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2M 4M 6M
RIBT Yearly Total Debt VS Total AssetsRIBT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M 40M

2.2 Solvency

  • Based on the Altman-Z score of -39.85, we must say that RIBT is in the distress zone and has some risk of bankruptcy.
  • RIBT has a worse Altman-Z score (-39.85) than 97.85% of its industry peers.
  • A Debt/Equity ratio of 3.78 is on the high side and indicates that RIBT has dependencies on debt financing.
  • RIBT has a worse Debt to Equity ratio (3.78) than 93.55% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.78
Debt/FCF N/A
Altman-Z -39.85
ROIC/WACCN/A
WACC7.79%
RIBT Yearly LT Debt VS Equity VS FCFRIBT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 0 10M -10M 20M 30M

2.3 Liquidity

  • A Current Ratio of 0.51 indicates that RIBT may have some problems paying its short term obligations.
  • RIBT's Current ratio of 0.51 is on the low side compared to the rest of the industry. RIBT is outperformed by 94.62% of its industry peers.
  • A Quick Ratio of 0.45 indicates that RIBT may have some problems paying its short term obligations.
  • The Quick ratio of RIBT (0.45) is worse than 84.95% of its industry peers.
Industry RankSector Rank
Current Ratio 0.51
Quick Ratio 0.45
RIBT Yearly Current Assets VS Current LiabilitesRIBT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M

3

3. RIBT Growth Analysis

3.1 Past

  • RIBT shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -8.77%.
  • The Revenue has grown by 19.84% in the past year. This is quite good.
  • Measured over the past years, RIBT shows a very strong growth in Revenue. The Revenue has been growing by 25.52% on average per year.
EPS 1Y (TTM)-8.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-212.24%
Revenue 1Y (TTM)19.84%
Revenue growth 3Y20.63%
Revenue growth 5Y25.52%
Sales Q2Q%-4.71%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
RIBT Yearly Revenue VS EstimatesRIBT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M 40M
RIBT Yearly EPS VS EstimatesRIBT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 -2 -4 -6 -8

0

4. RIBT Valuation Analysis

4.1 Price/Earnings Ratio

  • RIBT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RIBT Price Earnings VS Forward Price EarningsRIBT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RIBT Per share dataRIBT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. RIBT Dividend Analysis

5.1 Amount

  • No dividends for RIBT!.
Industry RankSector Rank
Dividend Yield N/A

RIBT Fundamentals: All Metrics, Ratios and Statistics

RICEBRAN TECHNOLOGIES

NASDAQ:RIBT (11/7/2023, 8:20:17 PM)

After market: 0.3675 +0.02 (+5%)

0.35

-0.01 (-1.69%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Industry Strength23.6
Industry Growth11.18
Earnings (Last)11-09
Earnings (Next)03-14
Inst Owners0.04%
Inst Owner Change0%
Ins Owners96.78%
Ins Owner Change0%
Market Cap2.31M
Revenue(TTM)32.98M
Net Income(TTM)-16.08M
Analysts43.33
Price Target4.59 (1211.43%)
Short Float %0%
Short Ratio0
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.07
P/FCF N/A
P/OCF N/A
P/B 2.57
P/tB 3.86
EV/EBITDA N/A
EPS(TTM)-2.48
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.64
FCFYN/A
OCF(TTM)-0.57
OCFYN/A
SpS4.99
BVpS0.14
TBVpS0.09
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -141.05%
ROE -1786.67%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-30.33%
ROA(5y)-30.36%
ROE(3y)-53.15%
ROE(5y)-47.52%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover2.89
Health
Industry RankSector Rank
Debt/Equity 3.78
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 27.88%
Cap/Sales 1.39%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.51
Quick Ratio 0.45
Altman-Z -39.85
F-Score3
WACC7.79%
ROIC/WACCN/A
Cap/Depr(3y)41.77%
Cap/Depr(5y)153.21%
Cap/Sales(3y)3.49%
Cap/Sales(5y)10.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-212.24%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)19.84%
Revenue growth 3Y20.63%
Revenue growth 5Y25.52%
Sales Q2Q%-4.71%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-6.19%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-8.76%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-25.33%
OCF growth 3YN/A
OCF growth 5YN/A

RICEBRAN TECHNOLOGIES / RIBT Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for RICEBRAN TECHNOLOGIES?

ChartMill assigns a fundamental rating of 1 / 10 to RIBT.


Can you provide the valuation status for RICEBRAN TECHNOLOGIES?

ChartMill assigns a valuation rating of 0 / 10 to RICEBRAN TECHNOLOGIES (RIBT). This can be considered as Overvalued.


What is the profitability of RIBT stock?

RICEBRAN TECHNOLOGIES (RIBT) has a profitability rating of 0 / 10.


Can you provide the financial health for RIBT stock?

The financial health rating of RICEBRAN TECHNOLOGIES (RIBT) is 0 / 10.